RBP4 and type 2 diabetes mellitus: Munkhtulga et al. conducted a case‒control study involving 511 control and 281 type 2 diabetes patients and revealed that the RBP4–803GA promoter polymorphism influences the binding of hepatic nuclear factor 1alpha and is associated with increased serum RBP4 levels in diabetic patients [63].